Type to search

MilliporeSigma Invests $286 Million in U.S. Drug Safety Testing Capacity | PTF
MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities | Pharmtech Focus